Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
Public Health,Bernie Sanders,US Senate,Johnson & Johnson,Drug Prices
From the Center
AllSides Media Bias Rating: Center
Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an investigation into high drug prices in the United States, he announced Thursday.
The step is highly unusual, as the health committee hasn’t issued a subpoena in more than 40 years.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
News
Under-reported Stories About Gun Regulations, Trump’s War on Drugs, and Canada’s MAID Program Demand a Closer Look
Malayna J. Bizier
August 24th, 2026
Story of the Week
Dr. Fauci Pleads the Fifth
AllSides Staff
July 30th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
